Statistics on Biotechnology Use  
Results by fields of operation
Sector Companies. Results in biotechnology for main variables and branches of activity 
Unidades: specified in variables

;Total Companies;Services;Industry and Construction;Agriculture;
No. of companies carrying out R&D in Biotechnology;1.233;740;405;89;
%Companies according to biotechnology used: Genetic code;31,7;41,6;15,1;24,8;
%Companies according to biotechnology used: Functional units;38,5;43,6;32,2;25,2;
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;22,8;27,7;14,6;19;
%Companies according to biotechnology used: Bioprocesses;53,4;43,1;76,8;32,3;
%Companies according to biotechnology used: Sub-cellular organisms;8,6;11,9;4,6;0;
%Companies according to biotechnology used: Bio-computing;22,3;31;9,6;7,1;
%Companies according to biotechnology used: Nanobiotechnology;10,6;13,8;6,9;1,1;
%Companies according to biotechnology used: Other;14,2;15,7;7,6;31,7;
Companies in which biotechnology activities are: Main and/or exclusive;615;485;113;17;
Companies in which biotechnology activities are: A secondary line of business;178;85;79;15;
Companies in which biotechnology activities are: A tool necessary for production;440;170;213;57;
%Company by field(s) of ultimate application of biotechnology use: Human Health;46,3;63,5;24,4;2,3;
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;16,2;17,8;11,8;23,5;
%Company by field(s) of ultimate application of biotechnology use: Food products;32;22,4;50;30;
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;24,6;23,1;18,7;63,4;
%Company by field(s) of ultimate application of biotechnology use: Environment;15,5;15;15,5;19,7;
%Company by field(s) of ultimate application of biotechnology use: Industry;12,9;13,5;14,1;2,3;
Personnel in R&D in biotechnology (no. of persons);13.444;8.462;4.143;840;
Personnel in R&D in biotechnology (no. of persons): Researchers;7.378;5.167;1.974;237;
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;6.066;3.295;2.169;603;
Personnel in R&D in biotechnology (no. of persons): women;7.501;4.900;2.238;363;
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;4.052;2.875;1.070;106;
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;3.450;2.025;1.168;257;
Personnel in R&D in biotechnology (FTE);9.401,9;5.991,3;2.869,8;540,9;
Personnel in R&D in biotechnology (FTE): Researchers;5.398,3;3.774,1;1.455,1;169,2;
Personnel in R&D in biotechnology (FTE): Technicians and assistants;4.003,6;2.217,2;1.414,7;371,7;
Personnel in R&D in biotechnology (FTE): women;5.426,2;3.510,7;1.654,8;260,7;
Personnel in R&D in biotechnology (FTE): (women) Researchers;3.016,4;2.104,1;830,3;82,1;
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;2.409,8;1.406,6;824,5;178,7;
Internal expenditure on R&D (thousands of euros);897.333;545.374;308.398;43.561;
1) By nature of the expense: Current expenses;817.409;495.422;283.561;38.426;
1.1) Remuneration to researchers;295.705;177.158;109.976;8.570;
1.2) Remuneration to technicians and assistants;156.853;84.448;62.043;10.362;
1.3) Other current expenses;364.852;233.816;111.542;19.494;
2) By nature of the expense: Capital expenses;79.924;49.952;24.837;5.135;
2.1) Land and buildings;10.272;5.381;2.529;2.362;
2.2) Equipment and instruments;56.609;35.410;19.076;2.123;
2.3) Acquisition of specific R&D software;4.839;2.768;1.974;97;
2.4) Otros productos de propiedad intelectual específicos para I+D;8.203;6.393;1.257;552;
1.1) By origin of the funds: Own funds;613.097;312.617;260.467;40.014;
1.2) By origin of the funds: From companies;86.085;76.374;9.711;0;
1.3) By origin of the funds: Public Administration funds;92.140;79.925;10.827;1.388;
1.4) By origin of the funds: From Universities;853;853;0;0;
1.5) By origin of the funds: From non profit private institutions;4.682;4.682;0;0;
1.6) By origin of the funds: Foreign funds;100.476;70.924;27.393;2.159;
Purchase of R&D services in biotechnology (thousands of euros);85.011;43.595;40.577;839;
Purchase of R&D services in biotechnology (thousands of euros): In Spain;54.243;18.614;34.957;672;
Purchase of R&D services in biotechnology (thousands of euros): Abroad;30.768;24.981;5.620;168;
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;39,2;49,7;23,8;22,7;
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;11,7;11,7;11,5;12;
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;12,5;13,6;10,5;12,9;
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;10,9;11,8;9,1;11,3;
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;14,3;17,6;8,5;13;
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels;16,5;20,8;9,3;13,6;
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;15;17,7;9,7;17;
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;36;40;30;32;
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;46,7;50,9;39,7;43,2;
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;19;21,6;14,2;19,5;
% Companies that have requested biotechnology patents in Biotechnology;17,3;22,1;10,4;9,4;
Number of patents requested;681;528;119;34;
% Companies with income of an international origin related to biotechnological activities;23;25,3;22,1;8,6;
% Turnover representing income of an international origin related to biotechnological activities;1,6;5,1;1,3;1,2;
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU;55,9;30,1;65,4;78,2;
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries;44,1;69,9;34,6;21,8;
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services;83,9;93,7;79,9;90;
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;14,7;2;20;0;
% Income of an international origin related with activities according to the classification: Operating source abroad;0,8;2,7;0;0;
% Income of an international origin related with activities according to the classification: Other;0,6;1,5;0;10;
Notas:
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute